Valuation

9995RemeGen

StockHKEXChinaHealth careEU retail investors: available

−1.5% today · −19.2% over a year

No score: too little data.

Stability: among the weakest. No dividend.

Ratios vs sector

Medians of Health care companies in the same region (stocks and REITs).

Lower P/E, P/B, P/S and EV/EBIT mean cheaper; higher yields, returns and margins mean more for the price. Negative multiples (losses) are left out of the medians.
Metric	9995	Sector median	vs median
P/E	—	25.3 · n=27	—
P/B	—	3.6 · n=45	—
P/S	—	4.4 · n=41	—
EV/EBIT	—	22.2 · n=29	—
Free-cash-flow yield	—	3.5% · n=41	—
Dividend yield	0.00%	0.10% · n=100	100% below
Return on equity	—	5.2% · n=56	—
Return on invested capital	—	6.6% · n=48	—
Gross margin	—	70.2% · n=40	—
Net debt / EBITDA	—	1.58 · n=26	—

The largest companies of the same sector and region.


NVSNovartis AG	22.2	6.7	18.6	5.7%	2.4%	10/10
NOVNNovartis AG	22.2	6.7	18.6	5.7%	2.8%	10/10
AZNAstraZeneca plc	28.3	5.9	22.8	4.1%	1.7%	6/10
AZNAstraZeneca PLC	28.3	5.9	22.8	4.1%	1.2%	6/10
NVONovo Nordisk A/S	11.7	6.2	10.2	4.9%	4.6%	7/10
SNYSanofi	13.2	1.4	17.9	7.0%	4.5%	7/10
SANSanofi SA	13.1	1.4	17.8	7.1%	4.9%	9/10
GSKGSK plc	14.3	5.0	11.6	7.8%	3.6%	10/10
TEVATeva Pharmaceutical Industries Limited	98.3	6.2	43.5	2.5%	0.0%	6/10
ALCAlcon	37.3	1.7	29.2	4.7%	0.4%	4/10

ratios computed by AI-Stock Invest from public filings and end-of-day prices

Withdraw from contract here · EU consumers: 14 days to withdraw from a purchase.